PHR
Price
$9.38
Change
+$0.03 (+0.32%)
Updated
Jun 18 closing price
Capitalization
579.8M
81 days until earnings call
Intraday BUY SELL Signals
VEEV
Price
$153.30
Change
-$1.55 (-1.00%)
Updated
Jun 18 closing price
Capitalization
24.9B
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PHR vs VEEV

PHR vs VEEV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PHR vs. VEEV commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHR is a Hold and VEEV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2026
Stock price -- (PHR: $9.38 vs. VEEV: $153.30)
Brand notoriety: PHR and VEEV are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: PHR: 93% vs. VEEV: 151%
Market capitalization -- PHR: $579.8M vs. VEEV: $24.9B
PHR [@Services to the Health Industry] is valued at $579.8M. VEEV’s [@Services to the Health Industry] market capitalization is $24.9B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $24.9B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHR’s FA Score shows that 0 FA rating(s) are green whileVEEV’s FA Score has 0 green FA rating(s).

  • PHR’s FA Score: 0 green, 5 red.
  • VEEV’s FA Score: 0 green, 5 red.
According to our system of comparison, both PHR and VEEV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHR’s TA Score shows that 4 TA indicator(s) are bullish while VEEV’s TA Score has 2 bullish TA indicator(s).

  • PHR’s TA Score: 4 bullish, 6 bearish.
  • VEEV’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, PHR is a better buy in the short-term than VEEV.

Price Growth

PHR (@Services to the Health Industry) experienced а +3.65% price change this week, while VEEV (@Services to the Health Industry) price change was -5.11% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.16%. For the same industry, the average monthly price growth was +2.73%, and the average quarterly price growth was -11.60%.

Reported Earning Dates

PHR is expected to report earnings on Sep 09, 2026.

VEEV is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Services to the Health Industry (-1.16% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VEEV($24.9B) has a higher market cap than PHR($580M). PHR has higher P/E ratio than VEEV: PHR (58.63) vs VEEV (27.18). VEEV YTD gains are higher at: -31.326 vs. PHR (-44.563). VEEV has higher annual earnings (EBITDA): 954M vs. PHR (42.3M). VEEV has more cash in the bank: 6.56B vs. PHR (74.7M). PHR (92.6M) and VEEV (95.9M) have identical debt. VEEV has higher revenues than PHR: VEEV (3.2B) vs PHR (496M).
PHRVEEVPHR / VEEV
Capitalization580M24.9B2%
EBITDA42.3M954M4%
Gain YTD-44.563-31.326142%
P/E Ratio58.6327.18216%
Revenue496M3.2B16%
Total Cash74.7M6.56B1%
Total Debt92.6M95.9M97%
FUNDAMENTALS RATINGS
PHR vs VEEV: Fundamental Ratings
PHR
VEEV
OUTLOOK RATING
1..100
8759
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8961
PRICE GROWTH RATING
1..100
6578
P/E GROWTH RATING
1..100
9894
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHR's Valuation (68) in the null industry is in the same range as VEEV (69) in the Packaged Software industry. This means that PHR’s stock grew similarly to VEEV’s over the last 12 months.

PHR's Profit vs Risk Rating (100) in the null industry is in the same range as VEEV (100) in the Packaged Software industry. This means that PHR’s stock grew similarly to VEEV’s over the last 12 months.

VEEV's SMR Rating (61) in the Packaged Software industry is in the same range as PHR (89) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

PHR's Price Growth Rating (65) in the null industry is in the same range as VEEV (78) in the Packaged Software industry. This means that PHR’s stock grew similarly to VEEV’s over the last 12 months.

VEEV's P/E Growth Rating (94) in the Packaged Software industry is in the same range as PHR (98) in the null industry. This means that VEEV’s stock grew similarly to PHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHRVEEV
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
62%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 3 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHR
Daily Signal:
Gain/Loss:
VEEV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORRF39.030.55
+1.43%
Orrstown Financial Services
LASR64.730.18
+0.28%
nLIGHT
LGCY11.17-0.03
-0.27%
Legacy Education Inc.
MDB332.75-1.94
-0.58%
MongoDB
PAVS0.15-0.02
-13.67%
Paranovus Entertainment Technology Ltd.

VEEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEEV has been loosely correlated with CLSK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VEEV jumps, then CLSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEEV
1D Price
Change %
VEEV100%
-1.00%
CLSK - VEEV
55%
Loosely correlated
+2.74%
COIN - VEEV
54%
Loosely correlated
-1.00%
RIOT - VEEV
50%
Loosely correlated
+2.44%
WEAV - VEEV
45%
Loosely correlated
-1.70%
WAY - VEEV
43%
Loosely correlated
+1.21%
More